Absology

Global Standard for In-Vitro Diagnostic Devices

Anyang, South Korea · Founded 2017 · $53.5M raised

Headquarters
Anyang
Employees
11–50
Founded
2017
Business Model
B2B
Total Funding
$53.5M
Last Round
$14.5M Venture RoundJan 2025
Rounds
3

About

Absology is a South Korean biomedical company founded in March 2017 that develops and manufactures in-vitro immunodiagnostic medical devices for point-of-care testing (POCT). Its core 'ABSOL' platform uses fluorescence immunoassay (FIA) and microfluidic technology to deliver rapid quantitative diagnosis of cancer markers, cardiac conditions, hormones, and sepsis — matching the accuracy of large lab equipment in a compact device. The company sells its diagnostic platforms and reagent kits to hospitals, clinics, and distributors in approximately 30 countries, and also offers veterinary diagnostics through its 'Absol VET' product line.

Summary

Absology is a Biotech company based in Anyang, South Korea, founded in 2017. It has raised $53.5M in total across 3 rounds, most recently a $14.5M Venture Round round in Jan 2025.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJan 2025
$14.5M

Sign up to see all 3 rounds

Series C through Venture Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Absology on Indexed.vc
<a href="https://indexed.vc/companies/absology"><img src="https://indexed.vc/api/badge/company/absology" alt="Absology on Indexed.vc" width="260" height="76" /></a>